Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 30, 2025

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

2.7K

Commercialization of Organoids.

Deepak Choudhury1, Aswathi Ashok1, May Win Naing1

  • 1Bio-Manufacturing Group, Singapore Institute of Manufacturing Technology (SIMTech), Agency for Science, Technology, and Research (A*STAR), 2 Fusionopolis Way, #08-04, Innovis, Singapore.

Trends in Molecular Medicine
|January 27, 2020
PubMed
Summary

Organoid technology is advancing rapidly for drug screening and disease modeling. This review covers recent commercialization progress, organoid biobanks, and the associated ethical and regulatory landscape.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards sustainable serum-free media development from alternative sources for cultivated meat.

Food research international (Ottawa, Ont.)·2026
Same author

Bridging the Gap in Cryopreservation: A Review of Cryoprotectant Innovation and Global Market Trends.

Bioengineering (Basel, Switzerland)·2026
Same author

Scaling up cultivated meat bioprocessing: a mechanistic review of computational fluid dynamics as a rational design tool.

Bioresource technology·2026
Same author

Cultivated ingredients: a strategic pivot for cultivated meat?

Trends in biotechnology·2026
Same author

Spheroid Sheets: A Scalable Platform for Producing Tissue Membrane Constructs.

Bio-protocol·2025
Same author

Transition from manual to automated processes for autologous T cell therapy manufacturing using bioreactor with expandable culture area.

Scientific reports·2025

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Drug Discovery

Background:

  • Organoids are three-dimensional cell cultures that mimic human organ structures and functions.
  • They have shown significant promise in various biomedical applications, including disease modeling and drug development.

Purpose of the Study:

  • To review the recent advancements in the commercialization of organoid technology.
  • To discuss the concept and implications of organoid biobanks.
  • To highlight the ethical and regulatory considerations in organoid research and its commercial applications.

Main Methods:

  • Literature review of recent scientific publications and industry reports.
  • Analysis of trends in organoid commercialization and biobanking.
  • Discussion of ethical and regulatory frameworks relevant to organoid technology.
Keywords:
commercializationin vitro modelsorganoidsstem cellstissue engineering

More Related Videos

Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening
10:49

Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening

Published on: January 10, 2025

1.2K
Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

751

Related Experiment Videos

Last Updated: Dec 30, 2025

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

2.7K
Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening
10:49

Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening

Published on: January 10, 2025

1.2K
Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

751

Main Results:

  • Significant progress has been made in translating organoid technology from research to commercial products.
  • The establishment of organoid biobanks is emerging as a key strategy for large-scale research and drug screening.
  • Ethical and regulatory challenges require careful consideration for responsible innovation and commercialization.

Conclusions:

  • Organoid commercialization is rapidly expanding, offering new avenues for drug discovery and personalized medicine.
  • Organoid biobanks represent a valuable resource but necessitate robust ethical and regulatory oversight.
  • Addressing ethical and regulatory issues is crucial for the sustainable growth and societal benefit of organoid technology.